Exchange: NASDAQ·Updated 04:30 PM EST

About LRMR

About

Larimar Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing treatments for patients suffering from complex rare diseases using a novel cell penetrating peptide technology platform. It also engages in the research, development, and commercialization of novel therapeutics for mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
71

Frequently Asked Questions

Advertisement|Remove ads.